VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹9.18 Cr | ₹29 Cr | ₹-15 Cr | ₹15 Cr | ₹26 Cr |
What is the latest Net Cash Inflow / Outflow ratio of VENUS REMEDIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹9.18 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹-15 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹26 Cr |
How is Net Cash Inflow / Outflow of VENUS REMEDIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.18 Cr | -68.35 | |
| Mar2024 | ₹29 Cr | Positive | |
| Mar2023 | ₹-15 Cr | Negative | |
| Mar2022 | ₹15 Cr | -42.89 | |
| Mar2021 | ₹26 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,223.2 Cr | 16.3% | 19.7% | 201.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,693.0 Cr | -1.7% | 4% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,270.0 Cr | -4.7% | -1.8% | 10.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,281.0 Cr | -3.7% | 4.5% | 42.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,422.0 Cr | -3% | 0% | 15.4% | Stock Analytics | |
| CIPLA | ₹104,915.0 Cr | -2.6% | -2.3% | -10.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 16.3% |
19.7% |
201.9% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses